Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HUGE

FSD Pharma (HUGE) Stock Price, News & Analysis

FSD Pharma logo

About FSD Pharma Stock (NASDAQ:HUGE)

Advanced Chart

Key Stats

Today's Range
$0.23
$0.23
50-Day Range
$0.08
$0.20
52-Week Range
$0.07
$1.68
Volume
N/A
Average Volume
10.14 million shs
Market Capitalization
$9.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.

Receive HUGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter.

HUGE Stock News Headlines

Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Why Elon Musk’s Robotaxi Dreams Are Premature
See More Headlines

HUGE Stock Analysis - Frequently Asked Questions

FSD Pharma Inc. (NASDAQ:HUGE) announced its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.11.

Based on aggregate information from My MarketBeat watchlists, some other companies that FSD Pharma investors own include Meta Platforms (META), SNDL (SNDL), AMC Entertainment (AMC), Ford Motor (F), NVIDIA (NVDA), Fiverr International (FVRR) and NIO (NIO).

Company Calendar

Last Earnings
11/14/2023
Today
4/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
NASDAQ:HUGE
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-17,900,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.33 per share
Price / Book
0.69

Miscellaneous

Free Float
36,695,000
Market Cap
$9.11 million
Optionable
Optionable
Beta
0.60
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:HUGE) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners